Synthesis of Fmoc-protected N δ -acetyl-N δ -(tert-butoxy)-L-ornithine has revealed it to be a metal-chelating amino-acid precursor. This protected amino acid was compatible with the preparation of ferrichrome peptides by standard Fmoc-based solid-phase peptide synthesis.
Introduction
Siderophores are iron(III)-chelating compounds produced by microorganisms such as bacteria and fungi that uptake iron ions under iron-deficient conditions. 1 Siderophores contain three bidentate functional groups (hydroxamate, catecholate, α-hydroxycarboxylate) which form an extremely stable hexadentate, octahedral complex with iron(III). The hydroxamate-type siderophore deferriferrichrysin (1) is a cyclic hexapeptide produced by Aspergillus oryzae (Fig. 1 ). 2 Deferriferrichrome (2) and deferriferricrocin (3) also belong to the hydroxamate family of siderophores, and are produced from Ustilago sphaerogena 3 and Aspergillus fumigatus, 4 respectively.
All cyclic hexapeptides contain three consecutive N δ -acetyl-N δ -hydroxy-L-ornithines (Aho), which are produced from L-ornithine in a biosynthetic process by L-ornithine-N δ -oxygenase [e.g., Ustilago maydis sid1 protein (Sid1) 5 and Aspergillus nidulans sidA protein (SidA) 6 ] and N δ -transacetylase 7 .
Hydroxamic acid has metal-chelating functional groups that enable it to form complexes with various metals. 8 For example, deferriferrichrysin also forms chelate complexes with aluminum(III), 9 gallium(III) 10 and chromium(III). 11 A 89 Zr complex of the hydroxamate-type siderophore desferrioxamine B (4) has been applied to immuno-positron emission tomography (PET) in which the 89 Zr complex is conjugated to monoclonal antibodies (mAbs) for visualization of small tumors. 12 Deferriferricrocin (3) and desferritriacetylfusarinine C (5) are the predominant siderophores produced by Aspergillus fumigatus. 13 68 Ga peptides of 3 and 5 have been investigated for PET-based diagnoses of invasive pulmonary aspergillosis (IPA). 14 These siderophore-metal chelate complexes can provide therapeutic and diagnostic agents, so identification of novel metal complexes of deferriferrichrysin derivatives would be of great interest.
There are two reports of the chemical synthesis of ferrichrome peptides containing three Aho residues. The first chemical synthesis of deferriferrichrome (2) was accomplished using L-δ-nitronorvaline by Keller-Schierlein and Maurer in 1969. 15, 16 In that process, the linear hexapeptide tert-butoxycarbonylglycyl-tris(L-δ-nitronorvalyl)-glycyl-glycine methyl ester 7 was prepared using the mixed anhydride method. After cyclization of linear peptide 7, reduction of the side-chain nitro group to a hydroxylamine group and subsequent acetylation produced deferriferrichrome (2) (Scheme 1). Kurita et al. also reported the total synthesis of ferrichrome using N δ -tosyl-N δ -benzyloxy-L-ornithine in 1974. 17 A linear hexapeptide, tert-butoxycarbonylglycyl-tris(N δ -tosyl-N δ -benzyloxy-L-ornithyl)-glycyl-glycine methyl ester 8, was prepared using N,N'-dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide (HOSu). After cyclization, removal of the tosyl group and acetylation of the protected cyclic hexapeptide 11
followed by hydrogenation afforded deferriferrichrome (2) (Scheme 1). However, these approaches are not applicable to the facile structure-activity relationship (SAR) studies of deferriferrichrysin derivatives because the liquid-phase syntheses were not particularly versatile.
In the present study, we investigated the synthesis of fully protected N δ -acetyl-N δ -hydroxy-L-ornithine, which can be utilized for the preparation of ferrichrome derivatives by Fmoc-based solid-phase peptide synthesis (SPPS). Additionally, formation of novel metal complexes of deferriferrichrysin was evaluated using the resulting cyclic peptides.
Results and discussion
2.1. Synthesis of fully protected N δ -acetyl-N δ -hydroxy-L-ornithine N α -Fmoc-protected N δ -acetyl-N δ -hydroxy-L-ornithine derivative 20 was designed as a 'building block' for Fmoc-based SPPS (Scheme 2). We expected that a side-chain C3 unit with a terminal functional group of ornithine could be constructed by manipulations of derivatives of glutamic acid.
Initially, the carboxylic acid in the commercially available Cbz-Glu(t-Bu)-OH 14 was protected with a benzyl group to afford an ester 15. After removal of the side-chain t-Bu group of 15, the resulting carboxylic acid was converted to an alcohol 16 by in situ preparation of a mixed anhydride followed by NaBH 4 -mediated reduction. Treatment of 16 with NsNH(Ot-Bu) 18, 19 under the Mitsunobu condition gave a protected hydroxylamine 17. The hydroxylamine 17 was converted to a protected hydroxamate 19 by removal of the Ns group and acetylation. Hydrogenation of 19 followed by N α -Fmoc protection provided the desired product 20. This synthetic scheme was applied to the large-scale synthesis of 20, in which 12 g of the key building block 20 was obtained from 30 g of the starting material 14 (29% in eight steps).
Preparation of ferrichrome peptides by Fmoc-based SPPS
Using the resulting amino acid 20, peptide resin 22 was prepared on a 2-chlorotrityl [(2-Cl)Trt] resin 21 using standard Fmoc-based SPPS (Scheme 3). The consecutive couplings of three protected Aho 20 using N,N'-diisopropylcarbodiimide (DIC)/HOBt proceeded smoothly as the standard amino acids. After treatment of the resin with 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), a protected linear peptide 23 was cyclized using diphenylphosphoryl azide (DPPA)/NaHCO 3 20,21 to give a cyclic peptide 24. Removal of the side chain-protecting groups in 24 provided deferriferrichrysin (1). The overall yield from resin loading was 8%.
To demonstrate the potential utility of the established protocol, deferriferrichrome (2) and deferriferricrocin (3) were also synthesized. These two compounds were obtained efficiently by merely altering the coupling components in SPPS. Spectral data showed good agreement with the reported spectra. 4, 22, 23 
Metal-chelating properties of deferriferrichrysin
Formation of the complex of deferriferrichrysin with various metals was investigated. We chose Table 1) . 24 Formation of a metal-deferriferrichrysin complex in the mixture was not observed using Sr(II), Y(III), In(III), Gd(III) or Re(I) (entries 2-6). When using Re(V), a deferriferrichrysin peak disappeared and a new peak was observed (t R = 15.9 min; entry 7). ESI-MS analyses revealed that the product in the Re(V) mixture (m/z 700) was not the expected Re(V)-deferriferrichrysin complex (m/z 931). However, the reduced deferriferrichrysin analog was obtained, in which three hydroxamate groups were converted to amide groups (entry 7). Alcohols work as reducing agents for transition metals including rhenium, 25 palladium 26 and ruthenium, 27 so Re(V) might be reduced by methanol to a reactive low-valent ion, which reduced deferriferrichrysin. When DMF was used as the solvent, fully reduced deferriferrichrysin was not observed. 28 
Conclusions
We established a facile synthetic protocol for a fully protected Aho derivative 20. Using this key component 20 for Fmoc-based SPPS, deferriferrichrysin and derivatives were synthesized. This facile synthetic protocol may be useful for the preparation of Aho-containing peptides to conduct SAR studies and structure-function relationship studies. We also identified two new metal-chelating complexes of deferriferrichrysin with Zr(IV) and Ti(IV). Some Zr(IV) and Ti(IV) complexes have been used as catalyst materials in chemical reactions such as olefin polymerization, [31] [32] [33] epoxidation, 34, 35 and aldol reaction. 36, 37 Hence, these new peptide-metal complexes could be novel reagents with unique reactivity. Further studies on the application of these deferriferrichrysin-metal complexes are in progress.
Experimental

Synthesis
General methods
All moisture-sensitive reactions were performed using syringe-septum cap techniques under an argon atmosphere and all glassware was dried in an oven at 80 °C for 2 h prior to use. The preparation and characterization of compounds 15, 38 and 16 39 were reported previously.
Benzyl (S)-2-[N-(benzyloxycarbonyl)amino]-5-[N-(tert-butoxy)-N-(2-nitrophenylsulfonyl)amino]pentanoate (17)
To a solution of the alcohol 16 39 
Benzyl (S)-2-[N-(benzyloxycarbonyl)amino]-5-[N-(tert-butoxy)amino]pentanoate (18)
To a stirred solution of crude ester 17 (91.2 mg) in DMF (1.5 mL) were added thiophenol ( 
Benzyl (S)-5-[N-acetyl-N-(tert-butoxy)amino]-2-[N-(benzyloxycarbonyl)amino]pentanoate (19)
To a solution of ester 18 (97.2 mg, 0.23 mmol) in CH 2 Cl 2 (4.5 mL) were added pyridine (36.5 μL, 
(S)-5-[N-Acetyl-N-(tert-butoxy)amino]-2-[N-(9-fluorenylmethoxycarbonyl)amino]pentanoic acid (20)
The 
Peptide synthesis
The By use of a procedure identical with that described for the preparation of 23, the protected linear peptides for deferriferrichrome (2) and deferriferricrocin (3) were obtained.
Deferriferrichrysin (1)
To a mixture of the resulting linear peptide 23 (55.6 mg) and NaHCO 3 (42.0 mg, 0.500 mmol) in DMF (40 mL) was added DPPA (53.9 μL, 0.250 mmol) at -40 °C. The mixture was stirred for 48 h with warming to room temperature and then filtered. The filtrate was concentrated under reduced pressure, followed by flash chromatography over silica gel with CHCl 3 -MeOH (9:1) to give the crude protected cyclic peptide 24. The crude peptide 24 was treated with 95% TFA (2 mL) at room temperature for 6 h. The mixture was poured into ice-cold dry Et 2 O (10 mL). The resulting powder was collected by centrifugation and the washed three times with ice-cold dry Et 2 O. The crude product was purified by preparative HPLC to afford the deferriferrichrysin 1 (6.1 mg, 0.0082 mmol, 
Deferriferrichrome (2)
By use of a procedure identical with that described for the preparation of the deferriferrichrysin 1, 
